Building Biotechnology: Starting, Managing, and Understanding Biotechnology Companies - Business Development, Entrepreneurship, Careers, Investing, Science, Patents and Regulations (Hardcover)

~ (Author) "Biotechnology inventions and products are changing paradigms in healthcare, agriculture, and industrial processes..." (more)
Key Phrases: United States, Nobel Prize, Orphan Drug Act (more...)

Editorial Reviews

Review

... a sound foundation for better understanding this exciting and rapidly changing line of commerce. -- RiskWorld

A terrific, plain-language introduction to a growing entrepreneurial sector. -- National Business Incubation Association

Product Description

Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that define the scope of biotechnology. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in more than fifteen advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Schulich; the Johns Hopkins biotechnology MS/MBA program; and extension programs at Berkeley and UC San Francisco. This second edition significantly expands upon the foundation laid by the first, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables.

See all Editorial Reviews

Product Details

• Hardcover: 320 pages
• Publisher: Thinkbiotech; 2 edition (August 1, 2006)
• Language: English
• ISBN-10: 0973467630
• ISBN-13: 978-0973467635
• Product Dimensions: 8.9 x 6.1 x 0.9 inches
• Shipping Weight: 12.8 ounces
• Average Customer Review: 4.2 out of 5 stars  See all reviews (16 customer reviews)
• Amazon.com Sales Rank: #692,216 in Books (See Bestsellers in Books)

Customer Reviews

Most Helpful Customer Reviews

13 of 15 people found the following review helpful:

4.0 out of 5 stars Biotech biz 101 , August 22, 2005

By	Ingo Leung (Hong Kong) - See all my reviews (REAL NAME)

This review is from: Building Biotechnology: Starting, Managing, And Understanding Biotechnology Companies (Hardcover)

Friedman's 'Building Biotechnology' provides a good holistic introduction to the business of biotech. It is concisely written in layman's terms, with short & sweet case studies through out the book. What I find weak about the book is its limited coverage on the important topic of biotech valuation (readers who are interested in that topic can check out Peter Boer's 'Technology Valuation Solutions', or Richard Razgaitis's 'Valuation and Pricing of Technology-based Intellectual Property').

8 of 9 people found the following review helpful:

5.0 out of 5 stars Compelling and worthwhile read, August 16, 2004

By	Nathaniel Warsh - See all my reviews (REAL NAME)

This review is from: Building Biotechnology: Starting, Managing, And Understanding Biotechnology Companies (Hardcover)

This book is an excellent introduction to the business of biotechnology and the concepts that drive the industry.

Friedman gives you exactly what you need to know to understand the fundamentals- the legal, business and scientific aspects of biotechnology are explained well and are easy to understand. I was most impressed with the mini-case studies that provide insights into the industry and helped me think more like an insider.

A compelling and worthwhile read for anyone thinking about investing in biotechnology companies, pursuing biotechnology patents, seeking capital or joining a start-up.

5 of 5 people found the following review helpful:

5.0 out of 5 stars Building Blocks, August 29, 2006

By	Barry M. Datlof "InfoWeb Communications" (College Station, TX United States) - See all my reviews (REAL NAME)

Yali's book is really an excellent starting point for many people interested in knowing the basics of the biotech world. This includes an increasingly broad number of people. First, I highly recommend this book for MBA students interested in careers in biotech and healthcare. Second, this book should be bought by every medical school and bioag research university and given to every new faculty member. Why in 2006 do we still find faculty members who have no clue about the technology commercialization process which has allowed their field to expand into a muli-billion dollar industry. Perhaps every bio grad student should be given a copy. The book covers much ground, sometimes quickly. If you are into the field, the book could have been longer and more detailed, but its emphasis is clearly introductory. The case examples are great learning tools and a bit of history for the industry. Learning from the successes and failures of others is not new, but perhaps the next version will include more historical perspective on the boom and bust in the industry. The cycles of mergers and acquisitions, public financing windows, and valuation fluctuations could be of increased value.
Overall this book is highly accessible and an enjoyable read. Go to the Glossary and see how many of the words you can accurately define. Yali keeps the amalgam of topics together through concise writing and useful case examples.